Overview
OncoDaily Medical Journal (ODMJ) is an international, peer-reviewed, open-access journal dedicated to advancing oncology research, clinical practice, and global cancer care. The journal is published by P53 Inc. (USA) and serves as a platform for the dissemination of high-quality, evidence-based research across the full continuum of cancer science and medicine. ODMJ acts as an official journal of the Immune Oncology Research Institute.
ODMJ was established in 2024, with its official launch announced in June 2024 as part of the expansion of OncoDaily into scholarly publishing. The journal is published online and holds the electronic ISSN 3067-6444.
ODMJ considers all submitted manuscripts under the strict condition that:
- the manuscript is the authors’ original work and does not duplicate any previously published material, including the authors’ own prior publications;
- the manuscript has been submitted exclusively to ODMJ, is not under consideration, peer review, acceptance, or in press at any other journal, and has not been published elsewhere in any form.
ODMJ accepts a range of manuscript types that reflect the scope of oncology research and clinical practice. All submissions must fall within the journal’s aims and scope and meet requirements of originality, scientific validity, and ethical compliance.
- Original Research Articles
- Clinical Studies and Clinical Trials
- Reviews
- Systematic Reviews and Meta-Analyses
- Short Reports / Brief Communications
- Case Reports / Case Series
- Perspectives, Opinions, and Commentaries
- Correspondence
- Editorials
- Letters to the Editor
- Trials in Progress
- Protocols
Podcasts can be provided as supplementary materials accompanying the articles.
Article Processing Charges
Currently, ODMJ does not charge authors any fees for manuscript submission, article processing, or publication.
Aims and Scope
ODMJ publishes original research articles, systematic reviews, meta-analyses, and clinical studies, as well as scholarly perspectives aimed at improving outcomes for patients with cancer worldwide. The journal emphasizes the publication of scientifically rigorous and methodologically robust research, clinically relevant and translational studies, and interdisciplinary contributions that advance the understanding, diagnosis, and treatment of cancer.
The journal covers a broad range of oncology disciplines, including molecular oncology, biomarker research, immuno-oncology, targeted therapies, clinical trials, radiation and surgical oncology, hematologic malignancies, epidemiology, real-world evidence, survivorship, palliative and supportive care, and patient-centered outcomes.
Publication Model and Frequency
ODMJ is an online-only journal operating under a continuous publication model. Peer-reviewed articles are published individually upon acceptance and completion of final production, without waiting for issue closure. Published articles are subsequently organized into annual volumes and issues for indexing, citation, and archival purposes.
Open Access Policy
ODMJ is an open access journal which means that all content is freely available without charge to the user or their institution. Users are allowed to read, download, copy, search, or link to the full texts of the articles, without asking prior permission from the publisher or the author.
Copyright and Licensing
ODMJ is an open-access journal. All research articles are freely available online immediately upon publication and are licensed to allow broad reuse, in accordance with the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Privacy Statement
The names and email addresses entered on this journal’s website will be used exclusively for the purposes of managing and supporting the journal’s activities. This information will not be shared, sold, or disclosed to any third party, nor used for any other purposes.
Indexing & Abstracting
Crossref